Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Westminster Pharmaceuticals LLC

US Class II Ongoing · initiated 2025-08-06

CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.

SUN PHARMACEUTICAL INDUSTRIES INC

US Class II Ongoing · initiated 2025-08-05

Presence of foreign substance: identified as aluminum.

Haleon US Holdings LLC

US Class III Ongoing · initiated 2025-08-05

Labeling: Label Mix-up: The outer carton is labelled Fresh Mint. The tube is labelled Cool Mint/Whitening. The toothpaste inside the tube is Fresh Mint as indic…

Cardinal Health Inc.

US Class II Ongoing · initiated 2025-08-05

Correct Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contained Enoxaparin Sodium Injection, 30 mg/0.3 mL

Vagifem® 10

Canada Type III Ongoing · initiated 2025-08-05

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

B BRAUN MEDICAL INC

US Class II Ongoing · initiated 2025-08-04

Lack of Assurance of Sterility; potential for fluid leakage at one of the weld sites.

B BRAUN MEDICAL INC

US Class II Ongoing · initiated 2025-08-04

Lack of Assurance of Sterility; potential for fluid leakage at one of the weld sites.

PFIZER INC

US Class II Ongoing · initiated 2025-08-04

Lack of Assurance of Sterility.

PFIZER INC

US Class II Ongoing · initiated 2025-08-04

Lack of Assurance of Sterility.

Cardinal Health Inc.

US Class II Ongoing · initiated 2025-07-30

CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

Cardinal Health Inc.

US Class II Ongoing · initiated 2025-07-30

CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

Cardinal Health Inc.

US Class II Ongoing · initiated 2025-07-30

CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

Exela Pharma Sciences LLC

US Class II Ongoing · initiated 2025-07-30

Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility